https://auntresodamid.com/iJugHxINePLH1VY/96561

Health News

Healthee secures M in an oversubscribed Series B round

Healthee secures $50M in an oversubscribed Series B round

New York-based Healthee, a healthcare benefits navigation platform, announced an oversubscribed $50 million Series B funding raise led by Key1 Capital.  Existing investors Group11, Fin Capital and Glilot Capital Partners also participated in the round.  The company said in a statement that it did not formally launch the raise but rather was approached by the […]

Healthee secures $50M in an oversubscribed Series B round Read More »

AI-driven cervical cancer screening comes to Ho Chi Minh City

AI-driven cervical cancer screening comes to Ho Chi Minh City

A program to screen women for cervical cancer using AI has been launched in Ho Chi Minh City in Vietnam. Community organisation Ho Chi Minh City Public Health Association (HPHA) partnered with listed Australian company TruScreen and its local distributor Gorton Health Services to run the community-based program, which aims to screen 260,000 women in the city over five years. 

AI-driven cervical cancer screening comes to Ho Chi Minh City Read More »

Nourish raises M as Trump tariffs put pressure on healthy food prices

Nourish raises $70M as Trump tariffs put pressure on healthy food prices

Nourish, a virtual nutrition counseling platform, announced it secured $70 million in a Series B funding round, bringing its total raise to $115 million. J.P. Morgan Private Capital’s Growth Equity Partners led the round, with participation from Y Combinator, Maverick Ventures, Thrive Capital, Atomico, G Squared, Pinegrove, Index Ventures and BoxGroup. WHAT IT DOES Nourish

Nourish raises $70M as Trump tariffs put pressure on healthy food prices Read More »

ConcertAI, Bayer join forces to advance precision oncology

ConcertAI, Bayer join forces to advance precision oncology

Healthcare data company ConcertAI announced a multi-year agreement with pharmaceutical and biotechnology giant Bayer to utilize ConcertAI’s Translational360 and AI SaaS offerings. The offerings use AI and machine learning-acquired insights to speed up clinical development in precision oncology. The agreement aims to utilize ConcertAI’s Translational360 offering, an integrated research-level longitudinal clinical molecular database that harnesses

ConcertAI, Bayer join forces to advance precision oncology Read More »

Equitage Ventures secures .3M to expand investments in senior care

Equitage Ventures secures $47.3M to expand investments in senior care

Early-stage AgeTech venture capital firm Equitage Ventures announced the final close of a new $47.3 million fund. The round was led by an investment team that includes Daniel Kaplan, Russell Hirsch (a cofounder of Generator Ventures) and Adam Kaplan (CEO of Solera Senior Living). WHAT IT DOES  Equitage Ventures provides capital, distribution and advice to

Equitage Ventures secures $47.3M to expand investments in senior care Read More »

Reveleer acquires Novillus to enhance health plan-provider collaboration

Reveleer acquires Novillus to enhance health plan-provider collaboration

California-based healthcare data and analytics company Reveleer has acquired Novillus, which offers a workflow platform for health plans.  Reveleer, formerly Health Data Vision, provides an AI-enabled platform for payers aimed at advancing value-based care. The company offers workflow, data and analytics tools for risk adjustment, quality improvement and member management. It also provides medical record

Reveleer acquires Novillus to enhance health plan-provider collaboration Read More »

Biolinq raises 0M for intradermal glucose sensor for type 2 diabetes

Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes

Biolinq, a health technology company developing precision multi-analyte wearable biosensors for metabolic health, announced it secured $100 million in Series C funding.  Alpha Wave Ventures led the round with participation from existing investors AXA IM Alts, M Ventures, LifeSci Venture Partners, RiverVest Venture Partners, Hikma Ventures, Taisho Pharmaceutical, Features Capital and Aphelion Capital. WHAT IT

Biolinq raises $100M for intradermal glucose sensor for type 2 diabetes Read More »

AI-driven ADHD screening using eye images developed in Korea

AI-driven ADHD screening using eye images developed in Korea

A new study from South Korea has demonstrated the use of AI models to possibly diagnose and stratify attention deficit hyperactivity disorder by analysing eye images. FINDINGS Researchers from Yonsei University Health System have used four machine learning models and the AutoMorph deep learning pipeline to analyse approximately 1,108 retinal fundus photographs from over 600

AI-driven ADHD screening using eye images developed in Korea Read More »

Hippocratic AI partners with UAE services provider to expand into Middle East, North Africa

Hippocratic AI partners with UAE services provider to expand into Middle East, North Africa

United Arab Emirates-based Burjeel Holdings, a healthcare services provider, and Hippocratic AI, a generative AI company developing safety-focused large language models for healthcare, announced a strategic partnership to alter healthcare delivery.  Burjeel Holdings operates in parts of the Middle East and North Africa. Hippocratic AI and Burjeel announced the alliance during the Abu Dhabi Global

Hippocratic AI partners with UAE services provider to expand into Middle East, North Africa Read More »

White House new COVID-19 page promotes Wuhan lab leak theory

White House new COVID-19 page promotes Wuhan lab leak theory

The White House has replaced a federal website that provided information about COVID-19 with a web page titled “Lab Leak: The True Origins of COVID-19” that cites the controversial theory that the virus was leaked from a Wuhan lab in China. The previous websites, covidtests.gov and covid.gov, provided information on treatment options for COVID-19, vaccinations

White House new COVID-19 page promotes Wuhan lab leak theory Read More »

Don’t miss latest news!

Select list(s):

We don’t spam! Read our [link]privacy policy[/link] for more info.

🕶 Relax!

Put your feet up and let us do the hard work for you. Sign up to receive our latest news directly in your inbox.

Select Your Choice:

We’ll never send you spam or share your email address.
Find out more in our Privacy Policy.

Scroll to Top